Thomas Jefferson University

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Niyazov, Alexander
One or more keywords matched the following items that are connected to Niyazov, Alexander
Item TypeName
Concept Aged
Concept Aged, 80 and over
Concept Antineoplastic Combined Chemotherapy Protocols
Concept Benzamides
Concept Bridged-Ring Compounds
Concept Humans
Concept Insurance Carriers
Concept Middle Aged
Concept Phenylthiohydantoin
Concept Retrospective Studies
Concept United States
Concept Patient Satisfaction
Concept Prostate-Specific Antigen
Concept Receptor, ErbB-2
Concept Cyclin-Dependent Kinases
Concept BRCA1 Protein
Concept BRCA2 Protein
Concept Recombinational DNA Repair
Concept Triple Negative Breast Neoplasms
Concept Poly(ADP-ribose) Polymerase Inhibitors
Concept Ataxia Telangiectasia Mutated Proteins
Academic Article Real-world Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020.
Academic Article Payer perceptions of the use of real-world evidence in oncology-based decision making.
Academic Article RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain.
Academic Article Payer perceptions on the use of patient-reported outcomes in oncology decision making.
Academic Article Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.
Academic Article Payer perceptions on the use of economic models in oncology decision making.
Academic Article Awareness and Availability of Routine Germline BRCA1/2 Mutation Testing in Patients with Advanced Breast Cancer in Germany.
Academic Article BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel.
Academic Article Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Mutation(s): Results of a Real-World Study from the United States, United Kingdom, and four EU Countries.
Academic Article Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2-negative advanced breast cancer from the United States, Europe, and Israel.
Academic Article Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.
Academic Article Clinical characteristics, treatment patterns, and outcomes in adult patients with germline BRCA1/2-mutated, HER2-negative advanced breast cancer: a retrospective medical record review in the United States.
Academic Article Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy.
Academic Article Treatment Patterns and Clinical Outcomes Among Patients With Metastatic Prostate Cancer Harboring Homologous Recombination Repair Mutations.
Academic Article Predicting Treatment Effects from Surrogate Endpoints in Historical Trials in First-Line Metastatic Castration-Resistant Prostate Cancer.
Academic Article Comparative efficacy and safety of talazoparib plus enzalutamide and other first-line treatments for metastatic castration-resistant prostate cancer.
Academic Article Racial Differences in Survival and Healthcare Resource Utilization Among Medicaid-Insured Adults With Metastatic Prostate Cancer.
Search Criteria
  • Poly ADP Ribose Polymerase
  • 1